Rablip-20 is formulated with Rabeprazole Gastro-resistant Tablets I.P. 20 mg, a proton pump inhibitor (PPI) that suppresses gastric acid secretion by inhibiting the H⁺/K⁺-ATPase enzyme system in the gastric parietal cells.
It is indicated for the treatment of gastroesophageal reflux disease (GERD), peptic ulcer disease, Zollinger–Ellison syndrome, and other acid-related conditions. By reducing excess stomach acid, Rablip-20 helps relieve symptoms such as heartburn, acid reflux, indigestion, and epigastric pain, and promotes healing of acid-induced damage to the gastric and duodenal mucosa.
The gastro-resistant tablet ensures that Rabeprazole is protected from stomach acid and released in the intestine for optimal absorption and efficacy. Rablip-20 should be taken as directed by a healthcare professional.
Reviews
There are no reviews yet.